AB
Canada
"Next generation CRISPR tools to model and interrogate cancer" will be presented by Marco Herold, Chief Executive Officer, Olivia Newton-John Cancer Research Institute; Head, School of Cancer Medicine, La Trobe University; Laboratory Head, Blood Cancer and Immunotherapy Lab
AB
Canada
"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion" will be presented by Giuseppe Leuzzi, Principal Investigator | Functional Genomics of Cancer Immunity. IFOM, The AIRC Institute of Molecular Oncology, MIlan, Italy.